Hofseth BioCare ASA Profit Margin

The latest profit margin for HBC.OL is -57.46% as of June 2026. That compares with -51.54% in the prior-year period — down 11.5% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Hofseth BioCare ASA's historical trend and sector peers before judging valuation or financial health.

Over the past year, HBC.OL's profit margin moved from -51.54% to -57.46% — a 11.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Hofseth BioCare ASA's valuation or profitability profile.

Against its sector companies, HBC.OL currently prints -57.46% for profit margin, while the sector average sits near 13.23%. That is roughly 534.5% below the sector mean. Large gaps often invite a closer look at Hofseth BioCare ASA's growth, margins, and balance sheet.

Profit Margin shows how effectively Hofseth BioCare ASA converts resources into returns. At -57.46%, HBC.OL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -51.54% in the prior-year period — down 11.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HBC.OL's profit margin (-57.46%), review year-over-year change from -51.54%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.